Skip to main content

5 Insightful Analyst Questions From Keurig Dr Pepper’s Q3 Earnings Call

KDP Cover Image

Keurig Dr Pepper’s third quarter was marked by robust revenue expansion and a strong market response, with management attributing the outperformance to continued momentum across its core beverage and coffee businesses. CEO Tim Cofer highlighted that “net sales accelerated in Q3,” driven by solid gains in both U.S. Refreshment Beverages and international markets, as well as successful pricing actions in the coffee segment. Additionally, the company maintained its operating margins despite inflationary pressures, signaling operational discipline amid a dynamic macroeconomic backdrop. Management’s focus on brand building, innovation, and productivity initiatives supported both top-line and bottom-line growth, even as input costs and tariffs increased.

Is now the time to buy KDP? Find out in our full research report (it’s free for active Edge members).

Keurig Dr Pepper (KDP) Q3 CY2025 Highlights:

  • Revenue: $4.31 billion vs analyst estimates of $4.15 billion (10.7% year-on-year growth, 3.8% beat)
  • Adjusted EPS: $0.54 vs analyst estimates of $0.54 (in line)
  • Adjusted EBITDA: $1.30 billion vs analyst estimates of $1.28 billion (30.1% margin, 1.1% beat)
  • Operating Margin: 23.1%, in line with the same quarter last year
  • Sales Volumes rose 6.4% year on year (4% in the same quarter last year)
  • Market Capitalization: $36.9 billion

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Keurig Dr Pepper’s Q3 Earnings Call

  • Dara Mohsenian (Morgan Stanley) asked about incremental synergy opportunities and visibility of cost savings from the JDE Peet’s integration. CEO Tim Cofer and Chief Transformation Officer Roger Johnson expressed increased confidence based on recent diligence and highlighted ongoing collaboration to refine synergy plans.

  • Kevin Grundy (BNP Paribas) questioned the rationale behind structuring the transaction as an acquisition and separation rather than a sale or spin-off. Chairman Robert Gamgort explained that combining with JDE Peet’s maximizes global scale and value, while Board member Pamela Patsley noted the importance of flexibility and stakeholder feedback.

  • Christopher Carey (Wells Fargo) inquired about the outlook for free cash flow and the circumstances in which additional financing options might be pursued. CFO Jane Gelfand clarified that free cash flow projections are based on multi-year targets and outlined a flexible approach to future capital raises.

  • Andrea Teixeira (JPMorgan) sought details on the $400 million synergy target and the conservatism of guidance given commodity volatility. Cofer and Johnson stated that detailed planning and external adviser input underpin their confidence, with further opportunities possible as integration advances.

  • Peter Grom (UBS) asked whether the long-term coffee segment guidance includes synergies and how elasticity and mix are trending. Management confirmed synergy inclusion and noted that pods remain resilient, with volume trade-offs manageable despite pricing actions.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will be monitoring (1) the pace and execution of the JDE Peet’s integration and synergy capture, (2) continued market share gains and new product adoption in core beverage and coffee categories, and (3) progress on deleveraging and capital structure milestones tied to the planned corporate separation. The effectiveness of inflation and tariff management will also be a key area of focus as external cost pressures persist.

Keurig Dr Pepper currently trades at $27.10, in line with $27.17 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free for active Edge members).

The Best Stocks for High-Quality Investors

Fresh US-China trade tensions just tanked stocks—but strong bank earnings are fueling a sharp rebound. Don’t miss the bounce.

Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  255.22
+11.00 (4.50%)
AAPL  267.70
-2.67 (-0.99%)
AMD  256.85
+0.73 (0.28%)
BAC  52.95
-0.50 (-0.94%)
GOOG  282.28
+0.46 (0.16%)
META  651.74
+3.39 (0.52%)
MSFT  520.00
+2.20 (0.42%)
NVDA  207.79
+5.30 (2.62%)
ORCL  257.28
-5.33 (-2.03%)
TSLA  470.45
+13.89 (3.04%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.